BF Biosciences Statistics

Total Valuation

BF Biosciences has a market cap or net worth of PKR 18.48 billion. The enterprise value is 18.51 billion.

Market Cap	18.48B
Enterprise Value	18.51B

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	n/a

Share Statistics

BF Biosciences has 88.33 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	n/a
Shares Outstanding	88.33M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	25.00M

Valuation Ratios

The trailing PE ratio is 33.12.

PE Ratio	33.12
Forward PE	n/a
PS Ratio	3.25
PB Ratio	5.35
P/TBV Ratio	7.47
P/FCF Ratio	72.63
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.16, with an EV/FCF ratio of 72.76.

EV / Earnings	46.29
EV / Sales	4.54
EV / EBITDA	24.16
EV / EBIT	25.60
EV / FCF	72.76

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.91.

Current Ratio	1.06
Quick Ratio	0.74
Debt / Equity	0.91
Debt / EBITDA	2.95
Debt / FCF	8.87
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	16.06%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	214.47
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.70
Average Volume (20 Days)	1,878,122

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BF Biosciences had revenue of PKR 4.08 billion and earned 399.91 million in profits. Earnings per share was 6.32.

Revenue	4.08B
Gross Profit	1.72B
Operating Income	723.03M
Pretax Income	600.03M
Net Income	399.91M
EBITDA	766.09M
EBIT	723.03M
Earnings Per Share (EPS)	6.32

Full Income Statement

Balance Sheet

The company has 2.23 billion in cash and 2.26 billion in debt, giving a net cash position of -32.31 million or -0.37 per share.

Cash & Cash Equivalents	2.23B
Total Debt	2.26B
Net Cash	-32.31M
Net Cash Per Share	-0.37
Equity (Book Value)	2.47B
Book Value Per Share	39.08
Working Capital	233.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 469.35 million and capital expenditures -214.93 million, giving a free cash flow of 254.42 million.

Operating Cash Flow	469.35M
Capital Expenditures	-214.93M
Free Cash Flow	254.42M
FCF Per Share	2.88

Full Cash Flow Statement

Margins

Gross margin is 42.06%, with operating and profit margins of 17.72% and 9.80%.

Gross Margin	42.06%
Operating Margin	17.72%
Pretax Margin	14.71%
Profit Margin	9.80%
EBITDA Margin	18.78%
EBIT Margin	17.72%
FCF Margin	6.24%

Dividends & Yields

BF Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	0.01%
Earnings Yield	2.16%
FCF Yield	1.38%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BF Biosciences has an Altman Z-Score of 1.22. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.22
Piotroski F-Score	n/a